Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01522768
Title Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

esophageal cancer

stomach cancer

Therapies

Afatinib + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California Los Angeles California 90033 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Memoral Sloan Kettering Basking Ridge Basking Ridge New Jersey United States Details
Memoral Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Rockville Centre Rockville Centre New York United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field